Peter Kies
Director of Finance/CFO bei INOVIO PHARMACEUTICALS, INC.
Vermögen: 312 758 $ am 31.03.2024
Profil
Peter D.
Kies is currently the Chief Financial Officer at Inovio Pharmaceuticals, Inc. Prior to this, he held the same position at Newgen Results Corp.
from 1996 to 2002.
He also served as Chief Financial Officer at Genetronics Biomedical Corp.
and as an Auditor at Ernst & Young LLP.
Additionally, he worked as a Controller at Cytel Corp.
Mr. Kies received his undergraduate degree from Alliant International University.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
28.02.2024 | 22 533 ( 0,10% ) | 312 758 $ | 31.03.2024 |
Aktive Positionen von Peter Kies
Unternehmen | Position | Beginn |
---|---|---|
INOVIO PHARMACEUTICALS, INC. | Director of Finance/CFO | 01.06.2002 |
Ehemalige bekannte Positionen von Peter Kies
Unternehmen | Position | Ende |
---|---|---|
Genetronics Biomedical Corp. | Director of Finance/CFO | 05.04.2005 |
Newgen Results Corp.
Newgen Results Corp. Advertising/Marketing ServicesCommercial Services Newgen Results Corp. provides customer relationship and database management services. The company offers dealerships with a complete suite of CRM tools. Its partners are automotive companies and dealers including Audi, BMW, Ford, General Motors, Hyundai, Jaguar, Kia, Mitsubishi, Land Rover, Volkswagen, and Volvo. The company was founded in 1982 and is located in San Diego, CA. | Director of Finance/CFO | 01.06.2002 |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Comptroller/Controller/Auditor | - |
Cytel Corp. | Comptroller/Controller/Auditor | - |
Ausbildung von Peter Kies
Alliant International University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
INOVIO PHARMACEUTICALS, INC. | Health Technology |
Private Unternehmen | 4 |
---|---|
Newgen Results Corp.
Newgen Results Corp. Advertising/Marketing ServicesCommercial Services Newgen Results Corp. provides customer relationship and database management services. The company offers dealerships with a complete suite of CRM tools. Its partners are automotive companies and dealers including Audi, BMW, Ford, General Motors, Hyundai, Jaguar, Kia, Mitsubishi, Land Rover, Volkswagen, and Volvo. The company was founded in 1982 and is located in San Diego, CA. | Commercial Services |
Genetronics Biomedical Corp. | Commercial Services |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Commercial Services |
Cytel Corp. |